TheDHVI Profile Banner
Duke Human Vaccine Institute Profile
Duke Human Vaccine Institute

@TheDHVI

Followers
1K
Following
1K
Media
375
Statuses
1K

Global leader in developing vaccines and therapeutics against HIV, COVID-19, and influenza, ready to respond to any new emerging infectious disease threats.

Durham, NC
Joined February 2018
Don't wanna be here? Send us removal request.
@TheDHVI
Duke Human Vaccine Institute
4 months
The Duke Human Vaccine Institute is sharing news, research, and departmental highlights on LinkedIn. Follow us to stay informed and connected: https://t.co/FxkwYCgzh3
0
0
0
@TheDHVI
Duke Human Vaccine Institute
8 months
Congratulations to Georgia Tomaras, PhD, recipient of Duke School of Medicine's 2025 Faculty Award for Research Mentoring, recognizing excellence in mentoring across clinical, translational, population health, and basic sciences. Read about the recipients https://t.co/VcExcRV2qA
0
0
1
@TheDHVI
Duke Human Vaccine Institute
8 months
Experts from DHVI, @PennMedicine & @harvardmed share the successes and challenges in the quest to develop an HIV vaccine in, “Status of HIV Vaccine Development: Progress and Promise”, published in @jiasociety for #HIVVaccineAwarenessDay. Read the article 🔗 https://t.co/aO1KDLwHxY
Tweet card summary image
onlinelibrary.wiley.com
Click on the article title to read more.
0
4
6
@DukeMedSchool
Duke University School of Medicine
10 months
.@Duke_Neurology's Laurie Sanders, PhD, whose lab is pioneering early detection of Parkinson’s, cautions that losing NIH funding could hinder future scientific breakthroughs. 🔗 Read more: https://t.co/zCpwoKhyeR @DukeU
0
5
8
@DukeCancer
Duke Cancer
10 months
DCI's Jenny Freedman, PhD, explains how a natural gene-splicing process can run amuck, producing prostate cancer cells. Her team's discovery provides a promising new target for cancer treatment. https://t.co/hIFd0b0m1Y @DukeHealth | @dukemedicine
0
3
4
@TheDHVI
Duke Human Vaccine Institute
10 months
A group of scientists at Duke and Harvard Universities have conducted a study that may show new promise for a potential HIV vaccine. Their vaccine produces antibodies that are broadly neutralizing against more than a third of the HIV strains in the U.S. https://t.co/QO7UbL5tbZ
Tweet card summary image
anl.gov
Protein crystallization at the SER-CAT beamline at Argonne’s Advanced Photon Source proved key to the discovery of a new HIV vaccine candidate.
0
0
3
@WebsEdgeScience
WebsEdge - Science
11 months
Uniting 24 labs across 11 institutions to tackle HIV-1 challenges, discover the groundbreaking work of @DukeHIVStrucBio! See how their work on HIV-1 entry, B-cell receptors & more is paving the way for potential cures. @TheDHVI @BiophysicalSoc #bps2025 https://t.co/3M1D4kgnyT
0
1
1
@PriyamvadaA_Lab
Priyamvada Acharya
11 months
@DukeHIVStrucBio is at the @BiophysicalSoc Annual Meeting. #BPS2025
0
4
13
@DukeMedSchool
Duke University School of Medicine
11 months
Duke University School of Medicine has been named a Global Virus Network (GVN) Center of Excellence. This recognition highlights Duke's significant contributions to virus research and global health. @TheDHVI @DukeGHI https://t.co/QM58h8YGeE
medschool.duke.edu
Duke University School of Medicine has joined the Global Virus Network (GVN) as one of its newest Centers of Excellence. Collaborating entities include the Duke Research and Discovery @RTP, the Duke...
0
1
10
@TheDHVI
Duke Human Vaccine Institute
11 months
Researchers at the Duke Human Vaccine Institute successfully created an HIV vaccine candidate that guides key immune cells along an evolutionary pathway to become broadly neutralizing antibodies. https://t.co/8oyLOLOa6q
corporate.dukehealth.org
DURHAM, N.C. – Researchers at the Duke Human Vaccine Institute successfully created an HIV vaccine candidate that guides key immune cells along an evolutionary pathway to become broadly neutralizing...
0
3
6
@Duke_CTSI
Duke Clinical and Translational Science Institute
1 year
New research by #DukeCTSI and Duke SSRI examines the trust and perspective of providers, patients and caregivers when they considered using machine learning-based prediction models for patients with kidney failure on dialysis. Details in @JAMIA_Journal: https://t.co/0xnwt5DO5A
0
1
1
@DukeHealth
Duke Health
1 year
Sore throat, cough, fever, and ear pain? Is it better to head to an urgent care or the emergency department if you’re having cold and flu-like symptoms? Follow along with the video below to test your knowledge and learn more. @DukeHospital | @DukeRegional | @DukeRaleigh
1
7
4
@Duke_CTSI
Duke Clinical and Translational Science Institute
1 year
🎉Congratulations to affiliate #DukeCTSI faculty @Keisha_Bentley and @senthil_selv, named to the 2025 Office for Faculty leadership programs at @DukeMedSchool! Dr. Bentley-Edwards joins ALICE: https://t.co/kWOHvtDjhi Dr. Selvaraj joins LEADER: https://t.co/Nugy2zLVw6
1
5
17
@niaidcivics
NIAID CIVICs
1 year
Meet Associate Scientist and Process Engineer with @TheDHVI, David Clarke! He has been working with the DHVI Good Manufacturing Program for seven years. He encourages junior scientists to use any opportunity for hands-on, experiential learning. #meetCIVICs
0
1
2
@PriyamvadaA_Lab
Priyamvada Acharya
1 year
Graduate student Ellie Zhang's cryo-EM structure, beautifully rendered by @swansolive made the cover of Science Translational Medicine. @dukebiochem @TheDHVI @DukeMedSchool @DukeU @AzoiteiLab
@ScienceTM
Science Translational Medicine
1 year
This week's issue of #ScienceTranslationalMedicine has arrived! Personalized electric stimulation shows promise in two patients with spinal cord injuries, a study shows that Staph bacteria rapidly evolve resistance to new antibiotic candidates, and more. https://t.co/1r8F7UFiDq
0
4
7
@DukeHealth
Duke Health
1 year
@DukeCancer formed a working group to tackle an alarming trend: the rising rates of young-onset gastrointestinal cancers. The group of experts representing diverse disciplines aims to identify significant risk factors in patients under 50. Read more ➡️ https://t.co/0xvs215iGN
1
5
4
@TheDHVI
Duke Human Vaccine Institute
1 year
Highly specific HIV antibodies could be induced by vaccination using a new strategy developed by DHVI researchers. Vaccination using this strategy may be able to counter the virus’s ability to outpace the immune system. https://t.co/AF4TFpK0KK
Tweet card summary image
corporate.dukehealth.org
DURHAM, N.C. – Highly specific HIV antibodies could be induced by vaccination using a new strategy developed by researchers at the Duke Human Vaccine Institute. Vaccination using this strategy may be...
0
1
3
@TheDHVI
Duke Human Vaccine Institute
1 year
Go to work with a view! You could make a difference in global health while providing essential support to researchers at the Duke Regional Biocontainment Laboratory as Program Assistant. If you have experience in office management & budgeting, apply at https://t.co/8d2a9XauJU.
0
0
0
@TheDHVI
Duke Human Vaccine Institute
1 year
Take your research career to the next level in the @lab_haynes as a Research Technician III. You'll play a critical role in characterizing immune responses using new & advanced techniques & work w/various specimens in a highly collaborative environment - https://t.co/NPq0uzD6qd.
0
0
0
@TheDHVI
Duke Human Vaccine Institute
1 year
We're #hiring a Program Assistant. Make a difference in global health while providing essential support to researchers & staff at the Duke Regional Biocontainment Laboratory (RBL). You'll play a vital role in supporting investigators and staff. Apply now- https://t.co/8d2a9XauJU.
careers.duke.edu
RBL STAFF ASSISTANT
0
2
1